These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 14984924
1. The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm. Olijhoek JK, van der Graaf Y, Banga JD, Algra A, Rabelink TJ, Visseren FL, SMART Study Group. Eur Heart J; 2004 Feb; 25(4):342-8. PubMed ID: 14984924 [Abstract] [Full Text] [Related]
2. Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm. Gorter PM, Olijhoek JK, van der Graaf Y, Algra A, Rabelink TJ, Visseren FL, SMART Study Group. Atherosclerosis; 2004 Apr; 173(2):363-9. PubMed ID: 15064114 [Abstract] [Full Text] [Related]
3. Abdominal fat and risk of coronary heart disease in patients with peripheral arterial disease. Brouwer BG, Visseren FL, Stolk RP, van der Graaf Y, SMART Study Group. Obesity (Silver Spring); 2007 Jun; 15(6):1623-30. PubMed ID: 17558001 [Abstract] [Full Text] [Related]
4. Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease in a Mediterranean cohort. Athyros VG, Liberopoulos EN, Mikhailidis DP, Papageorgiou AA, Ganotakis ES, Tziomalos K, Kakafika AI, Karagiannis A, Lambropoulos S, Elisaf M. Angiology; 2007 Jun; 58(6):689-97. PubMed ID: 18216378 [Abstract] [Full Text] [Related]
5. Serum uric acid levels and risk for vascular diseases in patients with metabolic syndrome. Hjortnaes J, Algra A, Olijhoek J, Huisman M, Jacobs J, van der Graaf Y, Visseren F. J Rheumatol; 2007 Sep; 34(9):1882-7. PubMed ID: 17696269 [Abstract] [Full Text] [Related]
9. Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients. Vlek AL, van der Graaf Y, Spiering W, Visseren FL, SMART study group. J Hum Hypertens; 2008 May; 22(5):358-65. PubMed ID: 18273039 [Abstract] [Full Text] [Related]
10. Metabolic syndrome and C-reactive protein among cardiology patients. Chapidze G, Dolidze N, Enquobahrie DA, Kapanadze S, Latsabidze N, Williams MA. Arch Med Res; 2007 Oct; 38(7):783-8. PubMed ID: 17845899 [Abstract] [Full Text] [Related]
12. BMI versus the metabolic syndrome in relation to cardiovascular risk in elderly Chinese individuals. He Y, Jiang B, Wang J, Feng K, Chang Q, Zhu S, Fan L, Li X, Hu FB. Diabetes Care; 2007 Aug; 30(8):2128-34. PubMed ID: 17468350 [Abstract] [Full Text] [Related]
13. The metabolic syndrome in type 2 diabetes: When does it matter? Wong J, Molyneaux L, Constantino MI, Twigg SM, Yue DK. Diabetes Obes Metab; 2006 Nov; 8(6):690-7. PubMed ID: 17026494 [Abstract] [Full Text] [Related]
14. Peripheral arterial disease in patients with stages IV and V chronic renal failure. Guerrero A, Montes R, Muñoz-Terol J, Gil-Peralta A, Toro J, Naranjo M, González-Pérez P, Martín-Herrera C, Ruiz-Fernández A. Nephrol Dial Transplant; 2006 Dec; 21(12):3525-31. PubMed ID: 16940320 [Abstract] [Full Text] [Related]
19. Cardiovascular risk factor management is poorer in diabetic patients with undiagnosed peripheral arterial disease than in those with known coronary heart disease or cerebrovascular disease. Results of a nationwide study in tertiary diabetes centres. González-Clemente JM, Piniés JA, Calle-Pascual A, Saavedra A, Sánchez C, Bellido D, Martín-Folgueras T, Moraga I, Recasens A, Girbés J, Sánchez-Zamorano MA, Mauricio D, PADiD Study Group. Diabet Med; 2008 Apr; 25(4):427-34. PubMed ID: 18341592 [Abstract] [Full Text] [Related]